TY  - JOUR
PY  - 2007//
TI  - An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefacept
JO  - Journal of drugs in dermatology
A1  - Magliocco, Melissa A.
A1  - Lozano, Ann Marie
A1  - Van Saders, Claudia
A1  - Schuler, Kristine W.
A1  - Gottlieb, Alice B.
SP  - 424
EP  - 427
VL  - 6
IS  - 4
N2  - Eleven patients with well-controlled psoriasis on cyclosporine (Physician's Global Assessment [PGA] of "mild" or better) participated in an open-label study that evaluated a strategy for transition to alefacept. Using this transition strategy, 7 of 11 patients (64%) maintained PGA scores. Quality of life improved or was maintained in all patients. Adverse events and reductions in CD4+ T cell counts were consistent with those seen during alefacept monotherapy.<p /> <p>Language: en</p>
LA  - en
SN  - 1545-9616
UR  - http://dx.doi.org/
ID  - ref1
ER  -